The Beauty Health Company (SKIN)
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.10 per share a year ago.
The Beauty Health Company (SKIN) Q4 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and Chief Executive Officer Mike Monahan - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Oliver Chen - TD Cowen Olivia Tong - Raymond James Ashley Helgans - Jefferies Jon Block - Stifel Navin Tsai - BNP Paribas Operator Good day and welcome to the Beauty Health Company Fourth Quarter and 2024 Full Year Earnings and Conference Call. [Operator Instructions] Please note this event is being recorded.
Beauty Health (SKIN) International Revenue Performance Explored
Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.
The Beauty Health Company Q2 2024 Earnings: Will It Ever Be Profitable?
At Moats and Monopolies, we focus on long only, high quality businesses but sometimes we like a little asymmetric risk/reward opportunity. The Beauty Health Company has been incredibly volatile over the past couple of years as investors have grown weary that the company may never be profitable. The company still isn't profitable, causing a sell off after earnings after a $17 million write off for replacing flagship models with technical issues combined with declining revenues.
The Beauty Health Company (SKIN) Q2 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Michael Monahan - CFO Conference Call Participants Alec Legg - Canaccord Genuity Allen Gong - JPMorgan Macauley Kilbane - William Blair Joseph Federico - Stifel Neil Goh - TD Cowen Operator Good afternoon, and welcome to The Beauty Health Company Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
Compared to Estimates, Beauty Health (SKIN) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Beauty Health (SKIN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
